According to the World Health Organization, there are 48 vaccine candidates in clinical trials and 164, still in the pre-clinical testing phase. Let’s analyze efficacy, safety and timing of the three the protagonists of this race.
Pier Giorgio Pacifici, Ph.D., IRBM’s Business Development Manager, and Stefania Di Marco, PhD, QP of ADVENT, will be attending the International Conference on Vaccines and Immunization in Rome on March 21st-22nd. The event unites renowned vaccination and immunology researchers to share exciting developments and cutting-edge innovations in this important field.
On March 21st at 1:30pm, Stefania will be delivering the “Production and Characterization of Viral Vectors for Vaccine Development” presentation at the conference’s keynote forum. ADVENT has a proven track record in the production of biological investigational medicinal products, with extensive experience in collaborating with both public and private institutions.
If you’d like to learn more about ADVENT’s development and manufacturing services then please get in contact with us to organize a meeting.